A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates

As new SARS-CoV-2 variants continue to emerge and impact communities worldwide, next-generation vaccines that enhance protective mucosal immunity may have a significant impact on productive infection and transmission. We have developed recombinant non-replicating adenovirus serotype 5 (rAd5) vaccine...

Description complète

Détails bibliographiques

Auteurs principaux:	Sarah N. Tedjakusuma, Colin A. Lester, Elena D. Neuhaus, Emery G. Dora, Samanta Gutierrez, Molly R. Braun, Sean N. Tucker, Becca A. Flitter
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-01-01
Collection:	Vaccines
Sujets:	adenovirus vaccines immunity mucosal SARS-CoV-2 immunoglobulin A
Accès en ligne:	https://www.mdpi.com/2076-393X/12/2/132
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!